Clinical Trial Update: Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of radiochemotherapy and immunotherapy for unresectable esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: UNICANCER | Conditions: Esophagus Cancer, Unresectable Malignant Neoplasm | Phase 2 | Status: COMPLETED